When the pair first met more than a decade ago, they were not just co-workers – they were also drug addicts. Ms Nur Azlinda Zulkifli was Mr Mohammad Hairi’s pusher who introduced him to meth. Now, the ...

This release is being retransmitted for extra exposure to downstream sites. SHELTON, CT / ACCESS Newswire / September 11, ...

Big Pharma faces unprecedented pressure as Trump administration attempts to enforce "most favored nation" drug pricing policy. Click for more on Pharma stocks.

Sept 2 (Reuters) - Zymeworks (ZYME.O), opens new tab said on Tuesday it will stop developing its experimental cancer drug after results from an early-stage trial showed the treatment was unlikely to ...

Ebrahimi is a scientific leader at GSK. Mrksich is the Henry Wade Rogers professor at Northwestern University, where he is developing the MegaMolecule technology for creating multifunctional ...

Indole, a molecule made up of a six-membered benzene ring fused to a five-membered ring containing nitrogen, forms the core structure of many biologically active compounds. Derivatives of indole, ...

WASHINGTON, DC—On Wednesday at the American Chemical Society Fall 2025 meeting, students and seasoned drug hunters alike gathered in a spacious third-floor ballroom of the Walter E. Washington ...

An Indiana-based drug research company said a recent ransomware attack has disrupted its business operations and forced a shutdown of critical systems. Inotiv told regulators at the Securities ...

The "The FDA (Food and Drug Administration) Drug Approval Process Training Course" training has been added to ResearchAndMarkets.com's offering.

Dr. Junzhou Huang has received a major federal grant to advance the use of artificial intelligence in antibody drug discovery. (Adobe Images) Junzhou Huang, Jenkins Garrett Endowed Professor in the ...

As drug costs rise and public trust falls, A.I. may transform the economics of clinical trials—and reshape the future of pharma. Unsplash+ Sixty percent of the total U.S. population takes at least one ...

Cardiovascular disease remains the leading cause of death worldwide, calling for the development of novel therapeutics. Over the past 3 decades, substantial investments in human genetic research have ...